Trials / Completed
CompletedNCT00828581
Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly Subjects
An Open-Label, Single-Dose Study of the Pharmacokinetic Properties of Lorcaserin in Obese or Overweight Elderly Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Eisai Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the PK properties of lorcaserin in obese or overweight elderly subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | lorcaserin |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2009-01-26
- Last updated
- 2023-06-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00828581. Inclusion in this directory is not an endorsement.